How is Glasdegib Oral Route dosed?
The recommended dose of Glasdegib for the treatment of acute myeloid leukemia in adults (75 years of age and older or with other medical conditions) is 100 mg orally, taken once a day, in combination with low-dose cytarabine. It is important to follow your doctor's instructions regarding dosage and duration of treatment, as it may vary depending on individual factors and medical conditions. Always consult with your healthcare provider for personalized dosing information.
What is the dosage form of Glasdegib Oral Route?
The dosage form of Glasdegib Oral Route is tablets.
How is Glasdegib Oral Route administered?
Glasdegib Oral Route is administered by taking a tablet with or without food, at about the same time each day. The tablet should be swallowed whole and not broken, crushed, or chewed. It is important to follow your doctor's orders or the directions on the label when taking this medicine.
What are common precautions when taking Glasdegib Oral Route?
Common precautions when taking Glasdegib Oral Route include:
- Allergies: Inform your doctor if you have had any unusual or allergic reactions to this medicine or any other medicines.
- Other types of allergies: Mention any allergies you have, such as to foods, dyes, preservatives, or animals.
- Pediatric use: Glasdegib has not been adequately studied in the pediatric population, so its safety and efficacy are not established.
- Geriatric use: Glasdegib has not demonstrated geriatric-specific problems limiting its usefulness in the elderly.
- Breastfeeding: There is limited information on the risks associated with using Glasdegib while breastfeeding. Consult your doctor before taking this medication.
- Drug interactions: Inform your doctor about all other medications you are taking, as there might be drug interactions with Glasdegib.